Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Viavi Solutions
VIAV
$10.7B
| $37.8M | 0.01% |
2,525,052
-1,074,324
| -30% | -$14.3M |
|
1127
PUT
Viatris
VTRS
$18.4B
| $37.8M | 0.01% |
2,017,748
+613,348
| +44% | +$10M |
|
|
1128
CALL
Analog Devices
ADI
$186B
| $37.8M | 0.01% |
255,900
-123,900
| -33% | -$16.4M |
|
1129
CALL
Newmont
NEM
$124B
| $37.8M | 0.01% |
630,756
-69,544
| -10% | -$4.29M |
|
1130
BioXcel Therapeutics
BTAI
$32.1M
| $37.6M | 0.01% |
50,890
+4,039
| +9% | +$3.15M |
|
1131
First Trust Enhanced Short Maturity ETF
FTSM
$6.54B
| $37.6M | 0.01% |
625,664
+515,722
| +469% | +$31M |
|
1132
MacroGenics
MGNX
$257M
| $37.5M | 0.01% |
1,641,261
+1,068,686
| +187% | +$24.6M |
|
1133
PUT
iShares US Real Estate ETF
IYR
$4.59B
| $37.5M | 0.01% |
438,000
-30,000
| -6% | -$2.5M |
|
1134
MongoDB
MDB
$37.7B
| $37.5M | 0.01% |
104,454
-176,941
| -63% | -$49.4M |
|
|
1135
PUT
Newmont
NEM
$124B
| $37.5M | 0.01% |
625,952
-126,448
| -17% | -$7.79M |
|
1136
PUT
Cleveland-Cliffs
CLF
$7.02B
| $37.3M | 0.01% |
2,563,040
-34,360
| -1% | -$348K |
|
1137
PUT
VanEck Oil Services ETF
OIH
$1.98B
| $37.3M | 0.01% |
242,275
-84,925
| -26% | -$10.8M |
|
1138
PUT
Akamai
AKAM
$18.2B
| $37.2M | 0.01% |
354,400
+109,600
| +45% | +$11.5M |
|
1139
Graco
GGG
$13.2B
| $37.2M | 0.01% |
514,117
+314,881
| +158% | +$21.1M |
|
1140
PUT
Rocket Companies
RKT
$42.1B
| $37.2M | 0.01% |
1,839,200
+371,800
| +25% | +$7.85M |
|
1141
iShares Short Maturity Bond ETF
NEAR
$4.89B
| $37.2M | 0.01% |
740,619
-47,780
| -6% | -$2.4M |
|
1142
8x8 Inc
EGHT
$299M
| $37.1M | 0.01% |
1,077,250
+781,778
| +265% | +$16.8M |
|
|
MRSH
1143
Marsh
MRSH
$89.8B
| $37.1M | 0.01% |
317,330
+241,079
| +316% | +$27.4M |
|
|
ABMD
1144
PUT
DELISTED
Abiomed Inc
ABMD
| $37M | 0.01% |
114,100
+16,600
| +17% | +$4.59M |
|
1145
Invesco
IVZ
$14.2B
| $36.9M | 0.01% |
2,119,295
+1,318,801
| +165% | +$20.3M |
|
1146
PUT
Plug Power
PLUG
$3.21B
| $36.8M | 0.01% |
1,085,600
+394,300
| +57% | +$8.93M |
|
1147
PPG Industries
PPG
$25.3B
| $36.8M | 0.01% |
+255,130
| New | +$35.5M |
|
1148
Guardant Health
GH
$21.2B
| $36.7M | 0.01% |
284,887
+44,351
| +18% | +$5.1M |
|
|
MZTI
1149
The Marzetti Company
MZTI
$3.2B
| $36.6M | 0.01% |
199,111
-32,768
| -14% | -$5.71M |
|
1150
PUT
Strategy Inc
MSTR
$37.1B
| $36.6M | 0.01% |
941,000
+817,000
| +659% | +$19.1M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.